AAAAAA

   
Results: 1-24 |
Results: 24
LATE REFERRAL OF END-STAGE RENAL-FAILURE
Authors: ELLIS PA REDDY V BARI N CAIRNS HS
Citation: Pa. Ellis et al., LATE REFERRAL OF END-STAGE RENAL-FAILURE, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(11), 1998, pp. 727-732
APOPTOTIC INDEX (AL) AND KI67 AS PROGNOSTIC FACTORS IN A TRIAL OF PRIMARY MEDICAL THERAPY (PMT) FOR PRIMARY-CARCINOMA OF THE BREAST
Authors: GREGORY RK ELLIS PA POWLES TJ DOWSETT M
Citation: Rk. Gregory et al., APOPTOTIC INDEX (AL) AND KI67 AS PROGNOSTIC FACTORS IN A TRIAL OF PRIMARY MEDICAL THERAPY (PMT) FOR PRIMARY-CARCINOMA OF THE BREAST, Annals of oncology, 9, 1998, pp. 23-23
RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: EISEN T SMITH IE JOHNSTON S ELLIS PA PRENDIVILLE J SEYMOUR MT WALSH G ASHLEY S
Citation: T. Eisen et al., RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1350-1357
ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS
Authors: DOWSETT M DETRE S ORMEROD MG ELLIS PA MAINWARING PN TITLEY JC SMITH IE
Citation: M. Dowsett et al., ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS, Cytometry, 32(4), 1998, pp. 291-300
REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY
Authors: ELLIS PA SMITH IE DETRE S BURTON SA SALTER J AHERN R WALSH G JOHNSTON SRD DOWSETT M
Citation: Pa. Ellis et al., REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY, Breast cancer research and treatment, 48(2), 1998, pp. 107-116
COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER
Authors: MAINWARING PN ELLIS PA DETRE S SMITH IE DOWSETT M
Citation: Pn. Mainwaring et al., COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER, Journal of Clinical Pathology, 51(1), 1998, pp. 34-37
A RANDOMIZED STUDY COMPARING 3-WEEKLY EPIRUBICIN, CYCLOPHOSPHAMIDE AND CONTINUOUS-INFUSION 5-FU (ECF) TO A 2-WEEKLY SCHEDULE WITH G-CSF IN ADVANCED BREAST-CANCER
Authors: DEBOER RH EISEN TG ELLIS PA JOHNSTON SRD WALSH G SMITH IE
Citation: Rh. Deboer et al., A RANDOMIZED STUDY COMPARING 3-WEEKLY EPIRUBICIN, CYCLOPHOSPHAMIDE AND CONTINUOUS-INFUSION 5-FU (ECF) TO A 2-WEEKLY SCHEDULE WITH G-CSF IN ADVANCED BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 40-40
PROCESSES USED BY NURSES TO MAKE DECISIONS IN THE CLINICAL-PRACTICE SETTING
Authors: ELLIS PA
Citation: Pa. Ellis, PROCESSES USED BY NURSES TO MAKE DECISIONS IN THE CLINICAL-PRACTICE SETTING, Nurse education today, 17(4), 1997, pp. 325-332
PREOPERATIVE CHEMOTHERAPY INDUCES APOPTOSIS IN EARLY BREAST-CANCER
Authors: ELLIS PA SMITH IE MCCARTHY K DETRE S SALTER J DOWSETT M
Citation: Pa. Ellis et al., PREOPERATIVE CHEMOTHERAPY INDUCES APOPTOSIS IN EARLY BREAST-CANCER, Lancet, 349(9055), 1997, pp. 849-849
INDUCTION OF APOPTOSIS BY TAMOXIFEN AND ICI-182780 IN PRIMARY BREAST-CANCER
Authors: ELLIS PA SACCANIJOTTI G CLARKE R JOHNSTON SRD ANDERSON E HOWELL A AHERN R SALTER J DETRE S NICHOLSON R ROBERTSON J SMITH IE DOWSETT M
Citation: Pa. Ellis et al., INDUCTION OF APOPTOSIS BY TAMOXIFEN AND ICI-182780 IN PRIMARY BREAST-CANCER, International journal of cancer, 72(4), 1997, pp. 608-613
ABSENCE OF P21 EXPRESSION IS ASSOCIATED WITH ABNORMAL P53 IN HUMAN BREAST CARCINOMAS
Authors: ELLIS PA LONNING PE BORRESENDALE A AAS T GEISLER S AKSLEN LA SALTER I SMITH IE DOWSETT M
Citation: Pa. Ellis et al., ABSENCE OF P21 EXPRESSION IS ASSOCIATED WITH ABNORMAL P53 IN HUMAN BREAST CARCINOMAS, British Journal of Cancer, 76(4), 1997, pp. 480-485
PRIMARY CHEMOTHERAPY FOR EARLY BREAST-CANCER
Authors: ELLIS PA SMITH IE
Citation: Pa. Ellis et Ie. Smith, PRIMARY CHEMOTHERAPY FOR EARLY BREAST-CANCER, Cancer treatment reviews, 22(6), 1996, pp. 437-450
COMPARISON OF MIB-1 PROLIFERATION INDEX WITH S-PHASE FRACTION IN HUMAN BREAST CARCINOMAS
Authors: ELLIS PA MAKRIS A BURTON SA TITLEY J ORMEROD MG SALTER J POWLES TJ SMITH IE DOWSETT M
Citation: Pa. Ellis et al., COMPARISON OF MIB-1 PROLIFERATION INDEX WITH S-PHASE FRACTION IN HUMAN BREAST CARCINOMAS, British Journal of Cancer, 73(5), 1996, pp. 640-643
ESTROGEN-RECEPTOR AND KI67 STATUS IN BREAST CARCINOMAS FOLLOWING PRIMARY CHEMOENDOCRINE THERAPY
Authors: ELLIS PA SALTER J BURTON S MAKRIS A SMITH IE POWLES T DOWSETT M
Citation: Pa. Ellis et al., ESTROGEN-RECEPTOR AND KI67 STATUS IN BREAST CARCINOMAS FOLLOWING PRIMARY CHEMOENDOCRINE THERAPY, European journal of cancer, 31A, 1995, pp. 687-687
DOSE INTENSIFICATION OF CARBOPLATIN AND ETOPOSIDE AS FIRST-LINE COMBINATION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: ELLIS PA TALBOT DC PRIEST K JONES AL SMITH IE
Citation: Pa. Ellis et al., DOSE INTENSIFICATION OF CARBOPLATIN AND ETOPOSIDE AS FIRST-LINE COMBINATION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, European journal of cancer, 31A(11), 1995, pp. 1888-1889
EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS
Authors: ELLIS PA NORMAN A HILL A OBRIEN MER NICHOLSON M HICKISH T CUNNINGHAM D
Citation: Pa. Ellis et al., EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS, European journal of cancer, 31A(10), 1995, pp. 1594-1598
A PILOT-STUDY OF MITOMYCIN, CISPLATIN AND CONTINUOUS-INFUSION 5-FLUOROURACIL (MCF) IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: ELLIS PA TALBOT DC NICOLSON MC PRIEST K ASHLEY S SMITH IE
Citation: Pa. Ellis et al., A PILOT-STUDY OF MITOMYCIN, CISPLATIN AND CONTINUOUS-INFUSION 5-FLUOROURACIL (MCF) IN ADVANCED NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 71(6), 1995, pp. 1315-1318
SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: ELLIS PA SMITH IE HARDY JR NICOLSON MC TALBOT DC ASHLEY SE PRIEST K
Citation: Pa. Ellis et al., SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 71(2), 1995, pp. 366-370
FLUDARABINE IN LYMPHOPROLIFERATIVE DISORDERS - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE
Authors: OBRIEN MER MATUTES E CUNNINGHAM D HILL M EMMETT E ELLIS PA MILAN S HICKISH T MERCIECA J CATOVSKY D
Citation: Mer. Obrien et al., FLUDARABINE IN LYMPHOPROLIFERATIVE DISORDERS - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE, Leukemia & lymphoma, 14, 1994, pp. 17-23
NEONATAL PLATELETS ARE LESS REACTIVE THAN ADULT PLATELETS TO PHYSIOLOGICAL AGONISTS IN WHOLE-BLOOD
Authors: RAJASEKHAR D KESTIN AS BEDNAREK FJ ELLIS PA BARNARD MR MICHELSON AD
Citation: D. Rajasekhar et al., NEONATAL PLATELETS ARE LESS REACTIVE THAN ADULT PLATELETS TO PHYSIOLOGICAL AGONISTS IN WHOLE-BLOOD, Thrombosis and haemostasis, 72(6), 1994, pp. 957-963
OPERATORS EYE CLOSER SERVICE RELATIONSHIPS
Authors: DEFFARGES EH ELLIS PA MCARTHUR NC
Citation: Eh. Deffarges et al., OPERATORS EYE CLOSER SERVICE RELATIONSHIPS, Oil & gas journal, 92(38), 1994, pp. 56-59
PLATELET ACTIVATION IN THE NEWBORN
Authors: RAJASEKHAR D KESTIN AS ELLIS PA ARELLANO BB NELSON MJ BEDNAREK FJ BARNARD MR MICHELSON AD
Citation: D. Rajasekhar et al., PLATELET ACTIVATION IN THE NEWBORN, Thrombosis and haemostasis, 69(6), 1993, pp. 1019-1019
EFFECT OF STRENUOUS EXERCISE ON PLATELET ACTIVATION STATE AND REACTIVITY
Authors: KESTIN AS ELLIS PA BARNARD MR ERRICHETTI A ROSNER BA MICHELSON AD
Citation: As. Kestin et al., EFFECT OF STRENUOUS EXERCISE ON PLATELET ACTIVATION STATE AND REACTIVITY, Circulation, 88(4), 1993, pp. 1502-1511
THE PLATELET-FUNCTION DEFECT OF CARDIOPULMONARY BYPASS
Authors: KESTIN AS VALERI CR KHURI SF LOSCALZO J ELLIS PA MACGREGOR H BIRJINIUK V OUIMET H PASCHE B NELSON MJ BENOIT SE RODINO LJ BARNARD MR MICHELSON AD
Citation: As. Kestin et al., THE PLATELET-FUNCTION DEFECT OF CARDIOPULMONARY BYPASS, Blood, 82(1), 1993, pp. 107-117
Risultati: 1-24 |